Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Chih-Ping Mao, M.D.,Ph.D.

Title
Institution
Department
Address
Profile Picture

Biography
Johns Hopkins School of Medicine, Baltimore, MDMD, PhDImmunology
Johns Hopkins University, Baltimore, MDBSMolecular & Cellular Biology

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Kang TH, Mao CP, Kim YS, Kim TW, Yang A, Lam B, Tseng SH, Farmer E, Park YM, Hung CF. TLR9 acts as a sensor for tumor-released DNA to modulate anti-tumor immunity after chemotherapy. J Immunother Cancer. 2019 10 16; 7(1):260. PMID: 31619293.
    Citations:    
  2. Song KH, Kim JH, Lee YH, Bae HC, Lee HJ, Woo SR, Oh SJ, Lee KM, Yee C, Kim BW, Cho H, Chung EJ, Chung JY, Hewitt SM, Chung TW, Ha KT, Bae YK, Mao CP, Yang A, Wu TC, Kim TW. Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance. J Clin Invest. 2018 08 31; 128(9):4098-4114. PMID: 30124467.
    Citations:    
  3. Mao CP, Peng S, Yang A, He L, Tsai YC, Hung CF, Wu TC. Programmed self-assembly of peptide-major histocompatibility complex for antigen-specific immune modulation. Proc Natl Acad Sci U S A. 2018 04 24; 115(17):E4032-E4040. PMID: 29632186.
    Citations:    
  4. Song KH, Choi CH, Lee HJ, Oh SJ, Woo SR, Hong SO, Noh KH, Cho H, Chung EJ, Kim JH, Chung JY, Hewitt SM, Baek S, Lee KM, Yee C, Son M, Mao CP, Wu TC, Kim TW. HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells. Cancer Res. 2017 09 15; 77(18):5039-5053. PMID: 28716899.
    Citations:    
  5. Lee SJ, Song L, Yang MC, Mao CP, Yang B, Yang A, Jeang J, Peng S, Wu TC, Hung CF. Local administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances dendritic cell cross-presentation. Vaccine. 2015 Mar 24; 33(13):1549-55. PMID: 25701675.
    Citations:    
  6. Lee YH, Bae HC, Noh KH, Song KH, Ye SK, Mao CP, Lee KM, Wu TC, Kim TW. Gain of HIF-1a under normoxia in cancer mediates immune adaptation through the AKT/ERK and VEGFA axes. Clin Cancer Res. 2015 Mar 15; 21(6):1438-46. PMID: 25589622.
    Citations:    
  7. Mao CP, Wu T, Song KH, Kim TW. Immune-mediated tumor evolution: Nanog links the emergence of a stem like cancer cell state and immune evasion. Oncoimmunology. 2014; 3(7):e947871. PMID: 25610734.
    Citations:    
  8. Kang TH, Mao CP, Lee SY, Chen A, Lee JH, Kim TW, Alvarez RD, Roden RB, Pardoll D, Hung CF, Wu TC. Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity. Cancer Res. 2013 Apr 15; 73(8):2493-504. PMID: 23418322.
    Citations:    
  9. Kang TH, Mao CP, La V, Chen A, Hung CF, Wu TC. Innovative DNA vaccine to break immune tolerance against tumor self-antigen. Hum Gene Ther. 2013 Feb; 24(2):181-8. PMID: 23268564.
    Citations:    
  10. Noh KH, Kim BW, Song KH, Cho H, Lee YH, Kim JH, Chung JY, Kim JH, Hewitt SM, Seong SY, Mao CP, Wu TC, Kim TW. Nanog signaling in cancer promotes stem-like phenotype and immune evasion. J Clin Invest. 2012 Nov; 122(11):4077-93. PMID: 23093782.
    Citations:    
  11. Kang TH, Mao CP, He L, Tsai YC, Liu K, La V, Wu TC, Hung CF. Tumor-targeted delivery of IL-2 by NKG2D leads to accumulation of antigen-specific CD8+ T cells in the tumor loci and enhanced anti-tumor effects. PLoS One. 2012; 7(4):e35141. PMID: 22509395.
    Citations:    
  12. Noh KH, Lee YH, Jeon JH, Kang TH, Mao CP, Wu TC, Kim TW. Cancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype. Cancer Res. 2012 Apr 01; 72(7):1717-27. PMID: 22337995.
    Citations:    
  13. Peng X, Mao C, Yu GY, Guo CB, Huang MX, Zhang Y, Ma L, Deng XL, Lin Y, Ma DQ, Meng ZQ, Zhang L. [Functional maxillary reconstruction with free composite fibula flap]. Beijing Da Xue Xue Bao Yi Xue Ban. 2011 Feb 18; 43(1):18-21. PMID: 21321612.
    Citations:    
  14. Mao CP, He L, Tsai YC, Peng S, Kang TH, Pang X, Monie A, Hung CF, Wu TC. In vivo microRNA-155 expression influences antigen-specific T cell-mediated immune responses generated by DNA vaccination. Cell Biosci. 2011 Jan 18; 1(1):3. PMID: 21711593.
    Citations:    
  15. Mao CP, Wu TC. Inhibitory RNA molecules in immunotherapy for cancer. Methods Mol Biol. 2010; 623:325-39. PMID: 20217561.
    Citations:    
  16. Mao CP, Hung CF, Kang TH, He L, Tsai YC, Wu CY, Wu TC. Combined administration with DNA encoding vesicular stomatitis virus G protein enhances DNA vaccine potency. J Virol. 2010 Mar; 84(5):2331-9. PMID: 20015980.
    Citations:    
  17. Chuang CM, Monie A, Wu A, Mao CP, Hung CF. Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer. Hum Gene Ther. 2009 Apr; 20(4):303-13. PMID: 19272013.
    Citations:    
  18. Huang B, Mao CP, Peng S, Hung CF, Wu TC. RNA interference-mediated in vivo silencing of fas ligand as a strategy for the enhancement of DNA vaccine potency. Hum Gene Ther. 2008 Aug; 19(8):763-73. PMID: 18627219.
    Citations:    
  19. Huang B, Mao CP, Peng S, He L, Hung CF, Wu TC. Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potency. Vaccine. 2007 Nov 07; 25(45):7824-31. PMID: 17931752.
    Citations:    
  20. Mao CP, Lin YY, Hung CF, Wu TC. Immunological research using RNA interference technology. Immunology. 2007 Jul; 121(3):295-307. PMID: 17428313.
    Citations:    
  21. Mao CP, Hung CF, Wu TC. Immunotherapeutic strategies employing RNA interference technology for the control of cancers. J Biomed Sci. 2007 Jan; 14(1):15-29. PMID: 17103251.
    Citations:    
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Mao's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (144)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.